...6 months of its fiscal year ending March 31, 2013, that it discontinued development of perflubutane...
...liver and breast lesions (see BioCentury, Aug. 20). Daiichi has rights to co-develop and market Sonazoid...
...Fairfield, Conn. Product: Sonazoid perflubutane ( DD-723-B ) Business: Diagnostic Molecular target: NA Description: IV perflubutane-based...

...expanded label for Sonazoid perflubutane to include ultrasound imaging of focal breast lesions. The IV perflubutane-based...
...country for ultrasound imaging of focal liver lesions. Daiichi has rights to co-develop and market Sonazoid...
...Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan General Electric Co. (NYSE:GE), Fairfield, Conn. Product: Sonazoid perflubutane ( DD-723-B...

...Acusphere said it completed an MAA dossier for Imagify perflubutane polymer microspheres to detect coronary artery...
...required for approval (see BioCentury, March 16, 2009). Acusphere Inc. (Pink:ACUSD), Lexington, Mass. Product: Imagify perflubutane...

...Industries Ltd. (NASDAQ:TEVA) Laquinimod Multiple sclerosis (MS) Ph III data 3Q11 Acusphere Inc. (Pink:ACUS) Imagify perflubutane...

...received an SPA from FDA for a planned placebo-controlled Phase III trial to evaluate Imagify perflubutane...
...required for approval (see BioCentury, March 16, 2009). Acusphere Inc. (Pink:ACUS), Tewksbury, Mass. Product: Imagify perflubutane...

...partners terminated a 2004 deal granting Nycomed exclusive rights to develop and commercialize Acusphere's Imagify perflubutane...

...after the company received a complete response letter from FDA for an NDA for Imagify perflubutane...

...Acusphere received a complete response letter from FDA for an NDA for Imagify perflubutane as an...
...12, 2004). Acusphere Inc. (Pink:ACUS), Watertown, Mass. Nycomed Group A/S , Zurich, Switzerland Product: Imagify perflubutane...

...when the company announced cost-cutting measures and submitted an amendment to its NDA for Imagify perflubutane...

...the company can fund operations beyond the anticipated May 31 PDUFA date for its Imagify perflubutane...